$ENVA

Fisher David sold $3.7M of ENVA

Fisher David (Executive Chairman) sold 20,750 shares of Enova International, Inc. (ENVA) at $178.24 ($3.70M total) on 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fisher David
Published Sep 21, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

The disclosed sale reduces insider ownership but is likely a routine liquidity move, offering limited trading edge.

02

Market read

Provides a modest, short‑term signal for ENVA traders; broader market impact is negligible.

03

What to watch

The 10b5‑1 plan indicates pre‑planned execution, reducing the informational content of the timing.

Relevance 5/10Novelty 5/10Timing: filed Sep 21, 2026

Background

Form 4 filings disclose insider transactions; investors monitor them for signals about management's view of the company.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Executive Chairman David Fisher sold 20,750 shares for $3.7M via a 10b5‑1 plan, reducing his stake to 306,444 shares.

Expected impact

Possible modest downward pressure in the next few trading sessions.

Evidence & confidence

A $3.7M sale by a top insider is material for a mid‑cap but not large enough to drive a sharp move; market may interpret it as a routine liquidity event.

Market effects

Minimal impact on the fintech lending sector; similar insider sales have not moved the broader industry.

U.S. market only; no regional ripple effect.

Low relevance globally.

Counterpoint

The sale could be a strategic diversification rather than a lack of confidence, suggesting the stock may still be undervalued.

Key entities

  • Enova International, Inc.

    U.S. fintech lender listed on NYSE under ENVA.

  • David Fisher

    Executive Chairman of Enova International.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMed

Citizens Cuts Enova’s Price Target after its Bank Deal Falls Apart

Citizens analyst David Scharf cut Enova's (NYSE:ENVA) price target to $215 from $270 after it abandoned a bank acquisition deal. Enova cited unclear standards and slow approvals. The company reaffirmed its guidance for 25% revenue growth and 30% adjusted EPS growth in Q3. For the full year, it expects 20-25% revenue growth and 30-35% adjusted EPS growth. Enova reported strong Q2 results with 22% revenue growth and 33% adjusted EPS growth. The company plans to accelerate share repurchases.

$ENVAMed

Why Enova International Stock Was Plummeting This Week

Enova International (NYSE: ENVA) withdrew applications for banking licenses, causing its stock to drop nearly 20% week-to-date. The company cited unclear authorization processes and plans to focus on its existing business. Enova reaffirmed its 2026 revenue growth forecast of 20-25% and adjusted net income per share growth of 30-35%.